Transgenic animals

R Jaenisch - Science, 1988 - science.org
The ability to introduce foreign genes into the germ line and the successful expression of the
inserted gene in the organism have allowed the genetic manipulation of animals on an …

Fetal nigral transplantation as a therapy for Parkinson's disease

CW Olanow, JH Kordower, TB Freeman - Trends in neurosciences, 1996 - cell.com
Fetal nigral grafts have been demonstrated to survive, secrete dopamine, form synaptic
connections with host neurons, and reverse behavioral disturbances in experimental models …

Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease: a detailed account of methodology and a 6-month follow-up

O Lindvall, S Rehncrona, P Brundin… - Archives of …, 1989 - jamanetwork.com
• By using stereotaxic surgical techniques, ventral mesencephalic tissues from aborted
human fetuses of 8 to 10 weeks' gestational age were implanted unilaterally into the striata …

Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies

JH Kordower, JM Rosenstein, TJ Collier… - Journal of …, 1996 - Wiley Online Library
A patient with Parkinson's disease received bilateral fetal human nigral implants from six
donors aged 6.5 to 9 weeks post‐conception. Eighteen months following a post‐operative …

Transplantation of human fetal dopamine cells for Parkinson's disease: results at 1 year

CR Freed, RE Breeze, NL Rosenberg… - Archives of …, 1990 - jamanetwork.com
• In an effort to improve the clinical signs of Parkinson's disease, we have implanted
mesencephalic dopamine cells from a 7-week human embryo into the caudate and putamen …

[图书][B] Intervening in the brain: changing psyche and society

R Merkel, G Boer, J Fegert, T Galert, D Hartmann… - 2007 - Springer
The Europäische Akademie is concerned with the study of the consequences of scientific
and technological advance both for the individual and for society at large as well as for the …

Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase

MJ During, JR Naegele, KL O'Malley, AI Geller - Science, 1994 - science.org
One therapeutic approach to treating Parkinson's disease is to convert endogenous striatal
cells into levo-3, 4-dihydroxyphenylalanine (L-dopa)-producing cells. A defective herpes …

Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis

H Widner, P Brundin - Brain Research Reviews, 1988 - Elsevier
The successful grafting of homotopic tissue (see Table 1 for terminology), ie neuronal tissue,
to the brain has recently increased the interest in the brain as an immunologically privileged …

Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a P arkinson disease patient

JH Kordower, CG Goetz, Y Chu, GM Halliday… - Annals of …, 2017 - Wiley Online Library
Objective The main goal of dopamine cell replacement therapy in Parkinson disease (PD) is
to provide clinical benefit mediated by graft survival with nigrostriatal reinnervation. We …

Stem-cell-based therapy: the celestial weapon against neurological disorders

MA Zayed, S Sultan, HO Alsaab, SM Yousof, GI Alrefaei… - Cells, 2022 - mdpi.com
Stem cells are a versatile source for cell therapy. Their use is particularly significant for the
treatment of neurological disorders for which no definitive conventional medical treatment is …